Lygend Resources & Technology Co., Ltd. (LYGEND RESOURCE, 02245) has announced senior management changes and an extension of a regulatory waiver from The Stock Exchange of Hong Kong Limited (HKEX).
Key Changes Effective 31 March 2026 • Mr. CHOW Shing Lung will resign as Joint Company Secretary, Authorised Representative (Rule 3.05) and Process Agent. • Ms. LEE Hoi Ki, currently with Computershare Hong Kong Investor Services, will assume all three roles on the same date. • Mr. CAO Zheng will remain as the other Joint Company Secretary.
Management Profiles • Ms. LEE brings more than 10 years of company secretarial and corporate-governance experience, holds a master’s degree in corporate governance from The Hong Kong Polytechnic University and is an associate of both The Hong Kong Chartered Governance Institute and The Chartered Governance Institute (UK). • Mr. CAO, Board Secretary since March 2023 and Joint Company Secretary since June 2023, holds degrees in law and management from Ningbo University and a master’s in international business law from the University of Leeds.
HKEX Compliance Waiver • HKEX previously granted a three-year waiver (effective 1 June 2023) under Listing Rules 3.28 and 8.17, allowing Mr. CAO to serve as Joint Company Secretary while gaining relevant experience. • Following Mr. CHOW’s resignation, HKEX has approved a new waiver covering the period from 31 March 2026 to 31 May 2026. Conditions include: – Mr. CAO must be assisted by Ms. LEE during the remaining waiver period. – HKEX may revoke the waiver for any material breach of Listing Rules. • Before the waiver expires, Lygend must demonstrate that Mr. CAO has acquired sufficient experience to fulfill company-secretary requirements independently.
Board Acknowledgement The Board expressed gratitude to Mr. CHOW for his service and welcomed Ms. LEE to her new positions.
Board Composition (announcement date: 31 March 2026) Executive Directors: CAI Jianyong (Chairman), FEI Feng, CAI Jianwei, WANG Ling Non-Executive Director: Lawrence LUA Gek Pong Independent Non-Executive Directors: Dr. HE Wanpeng, ZHANG Zhengping, Dr. WANG James Jixian Employee Representative Director: YU Weijun